KOTLER KEVIN
MELVILLE, NY · CIK 1601692 · 13F filing filed 2026-02-17
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
Options: 2 call positions ($22.7m notional), 2 put positions ($269.4m notional) – listed below, not included above.
This report includes the holdings of 1 other manager that shares the investment decisions:
- Broadfin Holdings LLC – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q4 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ANGIODYNAMICS INC ANGO | $22.0m16.25% | First filing |
| AURINIA PHARMACEUTICALS INC AUPH | $19.5m14.43% | First filing |
| AVADEL PHARMACEUTICALS PLC AVDL | $16.0m11.80% | First filing |
| OMEROS CORP OMER | $15.6m11.49% | First filing |
| NEUROPACE INC NPCE | $9.7m7.20% | First filing |
| MEDIWOUND LTD MDWD | $6.2m4.60% | First filing |
| AXOGEN INC AXGN | $5.5m4.06% | First filing |
| INTEGRA LIFESCIENCES HLDGS C IART | $5.3m3.92% | First filing |
| ACLARIS THERAPEUTICS INC ACRS | $5.1m3.79% | First filing |
| VERTICAL AEROSPACE LTD EVTL | $5.0m3.70% | First filing |
| ORASURE TECHNOLOGIES INC OSUR | $4.4m3.22% | First filing |
| GALAPAGOS NV LKFT | $2.9m2.17% | First filing |
| ELI LILLY & CO LLY | $2.1m1.59% | First filing |
| CERUS CORP CERS | $2.1m1.54% | First filing |
| NIKE INC NKE | $2.0m1.51% | First filing |
| TECTONIC THERAPEUTIC INC TECX | $1.7m1.23% | First filing |
| CLIMB BIO INC CLYM | $1.6m1.18% | First filing |
| TREACE MED CONCEPTS INC TMCI | $1.2m0.86% | First filing |
| TRISALUS LIFE SCIENCES INC TLSI | $1.0m0.75% | First filing |
| DEXCOM INC DXCM | $995.5k0.74% | First filing |
| VANDA PHARMACEUTICALS INC VNDA | $882.0k0.65% | First filing |
| ALIGN TECHNOLOGY INC ALGN | $680.7k0.50% | First filing |
| ONKURE THERAPEUTICS INC OKUR | $573.3k0.42% | First filing |
| GE AEROSPACE GE | $452.2k0.33% | First filing |
| PULMONX CORP LUNG | $442.0k0.33% | First filing |
| PTC THERAPEUTICS INC PTCT | $379.8k0.28% | First filing |
| DYCOM INDS INC DY | $355.1k0.26% | First filing |
| TAKEDA PHARMACEUTICAL CO LTD TAK | $311.8k0.23% | First filing |
| BETA BIONICS INC BBNX | $250.3k0.18% | First filing |
| ISHARES TR IHI | $242.5k0.18% | First filing |
| BANK AMERICA CORP BAC | $241.6k0.18% | First filing |
| AMAZON COM INC AMZN | $230.8k0.17% | First filing |
| ELANCO ANIMAL HEALTH INC ELAN | $205.3k0.15% | First filing |
| PLIANT THERAPEUTICS INC PLRX | $113.5k0.08% | First filing |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $238.7m350.0k shares | First filing |
| INVESCO QQQ TR QQQ · Put | $30.7m50.0k shares | First filing |
| AVADEL PHARMACEUTICALS PLC AVDL · Call | $19.0m879.4k shares | First filing |
| OMEROS CORP OMER · Call | $3.8m218.7k shares | First filing |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ANGIODYNAMICS INC ANGO · 13G · filed 2026-02-09 | 5.9%≈ $31.5m |